The Effect of Liposomal Bupivacaine Nerve Block (Exparel) in Rotator Cuff Surgery
Part of paid clinical trials in Camden, New Jersey.
- Sponsor
- The Cooper Health System
- Study ID
- NCT06139666
- Phase
- PHASE4
- Status
- Enrolling By Invitation
Conditions
- Opioid Use
- Postoperative Pain
- Rotator Cuff Tears
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Exparel Injectable Solution — DRUGPatients randomized to this arm will receive an interscalene block with Exparel solution, an extended-release formulation of bupivacaine (10cc liposomal bupivacaine + 15cc bupivacaine), approved for use at the study institution. This will be administered preoperatively on the day of surgery. The anesthesiologist administering the injection will be not be blinded to the mixture of injections (the surgeon and the patient will), which will be designated and randomized prior to administration. They will order and draw up the medication as they have been previously with no change in the standard of care. After surgery, the patient will be asked to keep a daily log of their pain scores, and the amount of narcotics will be counted by the physician at the first postoperative visit. The block would have been offered to the patient even if they are not part of the study. No additional visits are required. The only difference is the journal with pain score surveys and the pill count.
- Bupivacaine Injectable Solution — DRUGPatients randomized to this arm will receive a standard interscalene block consisting of 25 cc of bupivacaine alone. This will be administered preoperatively on the day of surgery. The anesthesiologist administering the injection will not be blinded to the mixture of injections (the surgeon and the patient will), which will be designated and randomized prior to administration. They will order and draw up the medication as they have been previously with no change in the standard of care. After surgery, the patient will be asked to keep a daily log of their pain scores, and the amount of narcotics will be counted by the physician at the first postoperative visit. The block would have been offered to the patient even if they are not part of the study. No additional visits are required. The only difference is the journal with pain score surveys and the pill count.
Study Details
The goal of this clinical trial is to investigate if there is a difference in pain after an arthroscopic rotator cuff surgery when a nerve block is performed with liposomal bupivacaine versus the standard treatment of bupivacaine alone. The main question aims to answer if patients who receive liposomal bupivacaine have better pain control and lower postoperative opioid consumption compared to bupivacaine alone. Participants be randomized to either the control group to receive a standard interscalene block with bupivacaine (25 cc of bupivacaine) or the experimental group to receive similar dosing of liposomal bupivacaine mixed with bupivacaine (10cc liposomal bupivacaine + 15cc bupivacaine). Data will be prospectively collected and the data from the experimental group will be compared to the control group at the completion of the study period.
Key Dates
- Start date
- Jul 11, 2019
- Status verified
- Aug 2024
- Primary completion
- Jun 1, 2024
- Completion
- Jun 1, 2025
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Control- Bupivacaine Alonepatients will receive a standard interscalene block with bupivacaine alone (25 cc of bupivacaine)
- Experimental: Study- Exparelpatients will receive an interscalene block with Exparel solution, which is an extended-release formulation of bupivacaine consisting of 10cc liposomal bupivacaine mixed with 15cc bupivacaine. This is approved and used at the study institution
Primary Outcome Measure
Use of pain medications [ Time Frame: 2 week postoperative visit ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cooper University Hospital | Camden | New Jersey | 08103 | - |
Find similar trials in Camden, NJ
Related Studies
- Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone TreatmentPHASE3 · Recruiting · Rutgers, The State University of New Jersey · New Brunswick, New Jersey
- Motivational Interviewing and Mindfulness-Oriented Recovery EnhancementPHASE3 · Recruiting · Rutgers, The State University of New Jersey · New Brunswick, New Jersey
- Exparel vs. Marcaine ESP Block for Post-cardiac Surgical PainPHASE2/PHASE3 · Enrolling By Invitation · Rutgers, The State University of New Jersey · New Brunswick, New Jersey
- Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid ConsumptionEnrolling By Invitation · The Cooper Health System · Camden, New Jersey